GlassScriptPhysician profile
Kimberly C Berni
NPI 1245289677
$14,129.17
in general payments reported to CMS, 2019-2025
49 companies · $1,747 in 2025
The $1,747 reported for 2025 was more than what 77% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,491 · 2020: $2,987 · 2021: $1,569 · 2022: $1,528 · 2023: $913 · 2024: $894 · 2025: $1,747.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,554.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,554.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $6,827.89 | 2019-2025 | Xtandi |
| Boston Scientific Corporation | $851.40 | 2019-2025 | Rezum Generator, General - Embolics, Spaceoar Vue System - 10ml |
| Stryker Corporation | $785.68 | 2019 | |
| Teleflex LLC | $772.94 | 2021-2025 | Urolift, Barrigel |
| Axonics, INC. | $408.40 | 2021-2023 | Bulkamid, Axonics |
| Pfizer INC. | $389.95 | 2019-2023 | |
| Janssen Biotech, INC. | $299.64 | 2019-2025 | Erleada |
| Neotract INC. | $280.70 | 2019-2020 | |
| Urogen Pharma, INC. | $275.40 | 2022-2025 | Jelmyto |
| Abbvie INC. | $219.18 | 2022-2025 | Botox |
| Cook Medical LLC | $172.61 | 2025 | Cook |
| Tolmar, INC. | $172.29 | 2023-2025 | Eligard, Jatenzo |
| Endo Pharmaceuticals INC. | $167.08 | 2019-2023 | Aveed, Xiaflex |
| Calyxo, INC. | $161.05 | 2025 | Cvac Aspiration System |
| Antares Pharma, INC. | $159.52 | 2023-2024 | Xyosted, Nocdurna, Tlando |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Berni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.